Post-traumatic stress disorder (PTSD) is associated with an increased risk of developing systemic lupus erythematosus (SLE), with emerging evidence linking chronic psychological stress to immune ...

Many lupus patients experience serious heart problems, ranging from heart valve disease to heart attacks, as a result of their disease activity. The following questions may help you better understand ...

The B-cell inhibitors market is experiencing robust growth, driven by the rising prevalence of the addressable patient population, which incl ...

(“Vasc” refers to blood vessels and “itis” means inflammation.) Vasculitis can be a diagnosis in itself but more often it coexists with lupus or another autoimmune disease and is then considered to be ...

Urticarial vasculitis (UV) is a small vessel vasculitis ... The patient is a 47-year-old male with a 6-year history of systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome.

Diagnosing systemic vasculitis remains a considerable clinical challenge, as does managing this disease after diagnosis. The general physician should have a working knowledge of vasculitis, including ...

Tenn. (WDEF) – Elisha R., a police detective and mother of two from Memphis, began experiencing sudden, itchy hives all over her body in late 2021. Using her natural investigative skills ...

Although all authors completed the disclosure declaration, the following author(s) and/or an author's immediate family member(s) indicated a financial or other interest that is relevant to the subject ...

Objectives X chromosome has been considered as a risk factor for SLE, which is a prototype of autoimmune diseases with a significant sex difference (female:male ratio is around 9:1). Our study aimed ...

I'm Dr. Susan Manzi. I am the chair of the Medicine Institute at Allegheny Health Network in Pittsburgh. I also direct our Lupus Center of Excellence and I have the privilege of serving as the Medical ...

Objective To determine the association between flares and HRQoL. Methods Patients from the Almenara Lupus Cohort were included. Visits occurring between December 2015 and February 2020 were evaluated.

They included 296 patients with new-onset or relapsing ANCA-associated vasculitis from four tertiary referral hospitals in South Korea who received either rituximab or cyclophosphamide as ...